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Abstract: The main challenge of interventions in penitentiary institutions is the re-education and
reintegration of inmates, i.e., that inmates have the intention and ability to live law-abiding lives.
Therefore, an increase in self-control or, on the contrary, the decrease or elimination of impulsive
versus compulsive behaviors becomes necessary. This study aimed to evaluate the role of impulsivity
versus compulsivity in treatment adherence in the prison population. The study included 134 men
from the Penitentiary Center of Granada who were divided into two groups. Group 1 was considered
treatment adherent, and Group 2 was considered non-adherent to treatment. The following instru-
ments were used: Symptom Inventory (SCL-90-R), Addiction Severity Index (EuropASI), Impulsivity
Scale (UPPS-P), and Compulsive Belief Questionnaire (OBQ-44). Statistically significant differences
were found in impulsivity in the dimensions of negative urgency, sensation seeking, and positive
urgency, with higher scores in all cases for the non-adherent group than for the adherent group. We
also found statistically significant differences in responsibility/inhibition, perfectionism/uncertainty,
and importance/control, with higher scores for the non-adherent group compared to the adherent
group. Treatment adherence is inversely related to impulsive and compulsive behaviors.
Keywords: impulsivity; compulsivity; treatment adherence; prison population
1. Introduction
Treatment adherence is defined as the degree to which the person’s behavior follows
the prescribed recommendations of the therapist. It includes the patient’s ability to at-
tend scheduled appointments, take prescribed medications, make recommended lifestyle
changes, and complete self-reports, tests, or homework assignments as requested [1,2].
There is currently considerable consensus [3] that physical activity and healthy eating
habits (consumption of fruits and vegetables) are fundamental behaviors in disease pre-
vention and indicate adherence to treatment. Along the same lines, a meta-analysis [4]
analyzing adherence in hospital and community interventions found that healthy eating
habits, community support, group intervention, and knowledge of the symptomatology
related to the disease being suffered are crucial elements in supporting adherence to treat-
ment. Moreover, individual factors (such as elderly age and treatment utility beliefs) impact
treatment non-adherence and affect treatment success in both chronic and acute diseases [5].
It has also been found [1,6] that non-adherence and noncompliance with homework are
related to personal variables, such as impulsivity. Impulsivity is associated with various
risky activities (potentially escalating to criminal acts) and poor treatment outcomes [7].
The American Psychiatric Association [8] defines impulsivity as a predisposition to un-
dertake rapid and unplanned reactions to internal or external stimuli without considering
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the negative consequences. Impulsivity has been consistently linked to a lack of behavioral
inhibition and is responsible for risky behaviors, such as drug use and aggression [9]. In
addition, behavioral inhibition is considered a fundamental component of executive func-
tion. Executive function is determined by complex cognitive processes involved in thought
control and mediated by the frontal lobe, more specifically, the prefrontal cortex [10].
Aggressive behavior has been associated with two distinct subtypes: impulsive and
premeditated (compulsive) [11]. Impulsive aggression is defined as an aggressive response
triggered by a provocation leading to loss of behavioral control, while premeditated
(compulsive) aggression is defined as an intentional or conscious aggressive act that is not
spontaneous or related to a state of agitation due to anger problems. The link between
aggression and impulsive or compulsive disorders has been associated with inefficient
frontal lobe function and are terms that reflect complex neurocircuitry [12].
Impulsivity and compulsivity are thought to underlie violent behaviors. Impulsivity
is related to decreased cognitive control, increased risk-taking, and behavioral disinhibition
(e.g., drug addiction). Compulsivity is associated with an excess of behavioral control that
can lead to an initial reluctance to engage in a particular behavior and ultimately promote
repetitive behaviors and avoidance of harm, e.g., violent acts might be carried out without
warning (impulsive act) or after a great deal of rumination (compulsive act) [13]. Recent
advances in understanding the neurocircuitry of impulsivity and compulsivity have led to
the idea that many maladaptive behaviors, such as the commission of crimes, share these
two dimensions (impulsivity and compulsivity). Impulsive and compulsive disorders,
including aggression and thus the commission of crimes, are caused in part by inefficient
information processing in executive functions [12]. Impulsive and compulsive behaviors
are both characterized by the inability to inhibit or delay behavior, which is related to the
prefrontal cortex. Compulsive behavior appears to be associated with increased frontal
lobe activity, whereas impulsive behavior may be associated with reduced activity in this
region [14]. The functions of the prefrontal cortex are to inhibit specific behaviors or actions,
i.e., to override impulsive and compulsive tendencies and to make decisions. Therefore,
damage to the prefrontal cortex may interfere with the functioning of these processes
(impulsivity and compulsivity). To date, no studies have analyzed the role of compulsivity
in treatment adherence. Thus, the present study aimed to evaluate the role of impulsivity
versus compulsivity in treatment adherence in the prison population.
To achieve the objectives of this study, we first proceeded to verify whether the
impulsivity variable assessed through the Impulsivity Scale (UPPS-P [15]) differed be-
tween the groups. Second, we checked whether compulsivity assessed through the self-
report Obsessive-Compulsive Belief Questionnaire (OBQ-44; [16]) also differed between
the groups (adherent versus non-adherent).
2. Materials and Methods
2.1. Study Design and Setting
The present study employed a cross-sectional observational design using standardized
assessment instruments adapted to the Spanish population. A total of 134 males from the
Granada Penitentiary Center with a mean age of 37.48 years (SD = 8.31; 20–54 years) partic-
ipated in this study. Participants were receiving a reintegration intervention implemented
by the prison team. Cognitive-behavioral and psychoeducational therapy were included as
part of this treatment. The participants were divided into two groups based on criteria of
the specialized prison technical staff and considering the recommendations of the reviewed
literature on treatment adherence [1,17]. Group 1 was considered treatment adherent and
comprised 56 men with a mean age of 38.7 years (SD = 7.6). Group 2 was considered non-
adherent and consisted of 78 men with a mean age of 36.6 years (SD = 8.7). The inclusion
criteria were serving a sentence in the said penitentiary center and voluntarily participating
in the study. Exclusion criteria were being over 55 years, having a physical or psychiatric
illness (schizophrenia and/or depression), and receiving current psychopharmacological
treatment for the diagnosed illness. To assess the exclusion criteria, participants completed
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the Symptom CheckList (SCL-90-R; [18]). Participants were informed about the aims of the
study and provided signed informed consent to participate anonymously.
The socio-demographic data and those related to drug use and crimes were handled
by the prison team that collaborated in this study with the patients’ consent. Table 1
displays the socio-demographic characteristics of the participants as well as those related
to drug use, crimes, and convictions.









Cohabiting with a partner 9 23
Educational Level (N) 3.302 0.347
No Primary 10 13
Primary 21 37
Secondary/High School 25 26
Undergraduate/Bachelor’s Degree 0 2
Type of Crime 1 (N) 13.630 0.009
Against life and integrity 4 7
Against Freedom 2 4
Against Property/ Treasury 29 47
Against Public Health 11 1
Gender Violence 10 19
Type of Crime 2 (N) 9.112 0.105
No crime 10 6
Against life and integrity 6 16
Against Freedom 1 2
Against Property; Public Treasury 28 42
Against Public Health 8 12
Gender Violence 3 0
MEAN (SD) MEAN (SD) F p
Time of Sentence Served 89.71 (71.53) 103 (91.57) 0.819 0.367
Time of Sentence Served in Prison 39.73 (42.39) 54.26 (49.27) 3.176 0.077
EuropASI MED (DT) MED (DT) F p
Physical/health 3.02 (2.15) 3.63 (2.35) 2.353 0.127
Employment 7.91 (1.77) 8.40 (1.28) 3.406 0.067
Alcohol 3.63 (2.20) 4.09 (2.12) 1.515 0.221
Drugs 4.89 (2.20) 4.82 (2.06) 0.038 0.846
Legal 9.00 (0.00) 9.00 (0.00)
Family 3.52 (2.75) 3.82 (2.39) 0.460 0.499
Psychological 7.46 (2.84) 8.23 (2.06) 3.292 0.072
Total Score 39.43 (6.08) 41.99 (5.62) 6.303 0.013
Addiction Severity Index—Addiction Severity Index.
2.2. Procedure and Instruments Used
First, participants were interviewed individually to check the inclusion criteria and to
confirm their participation in the research. Participants were reminded at the beginning of
the session of their right to discontinue the procedure at any time, and their written consent
was then obtained. The participants filled the measurements of this study as pen-and
paper by the participants themselves. This process was supervised by psychologists. All
patients were informed about the study course and methods, and about the possibility
of withdrawing from the study at any time. All patients provided their written informed
consent to participate in the anonymous survey.
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The participants were receiving intervention for their reintegration, implemented by
the prison team. This is a program designed to modify criminal behavior for positive
development within the prison in the short term and reinsertion and rehabilitation in the
long term. Prison treatment is regulated in Section III of the 1979, General Penitentiary
Organic Law (LOGP), Articles 59 to 72, and in Section V of the 96 Regulations, Articles 110
to 153. According to Article 59 of the LOGP [19], prison treatment consists of a series of
activities aimed at achieving re-education and reinsertion. The goal of the treatment is to
ensure that the inmate has the intention and ability to live in a manner that respects the
criminal law, and to advise on their needs. Therefore, it covers four fundamental areas:
regulatory, well-being, training-cultural-employment, and the therapeutic area [20]. Within
the therapeutic area, one of the priority objectives in the prison setting is to enable inmates
to live without drugs. As part of the treatment, participants received cognitive-behavioral
and psychoeducational therapy. The program combines individualized, or group actions
developed by the prison psychologist to manage emotions, cognitions, and behaviors that
impede the development of adequate self-control on the part of the inmate.
Treatment adherence was determined through the reports recorded by the psychologist
of the module to which the participants belonged. These reports had been prepared in
accordance with the published proposals [1,17] on the key elements to be considered
when preparing a treatment adherence report. These elements were: Compliance with
out-of-session activities after the intervention session (known as homework); completion
of self-reports; maintenance of abstinence from alcohol and drug use (tobacco was not
included); attendance at therapeutic sessions, attendance at workshops; participation in
leisure activities programmed by the prison in the sociocultural center (e.g., cinemas,
concerts, and conferences); daily physical activity; maintenance of personal cleanliness,
personal area (cell), and common areas; eating the food prepared in the prison center
(because it is balanced and healthy) and avoiding buying and eating junk food from the
commissary. This information was transformed into a dichotomous variable (adherence,
non-adherence).
The measurements used in this study are described below:
Report on demographic variables, crimes, and behaviors in institutions. This re-
port was completed by the prison psychologist who was responsible for collecting socio-
demographic data, along with information on the types of offenses and penalties, and
sanctions within the prison following the prison regulations [21].
The Symptom Checklist (SCL-90-R; [18]). This is a symptom scale that evaluates the
degree of psychological distress experienced by a person for a period of one week prior to
the time of assessment. It consists of 90 items (a reduced version of 52) with a Likert-type
scale composed of five response options. This instrument is structured into nine pri-
mary dimensions (somatizations—SOM, obsessions and compulsions—OBS, interpersonal
sensitivity—IS, depression—DEP, anxiety—ANS, hostility—HOS, phobic anxiety—FOB,
paranoid ideation—PAR, and psychoticism—PSIC), seven additional items (referring to
sleep disorders, eating behavior, thoughts about death and feelings of guilt), and three
global distress indices (Global Severity Index—GSI, is an indicator of the current level of
perceived distress, total positive symptoms—TSP refers to the total number of symptoms
recognized as present, and the Positive Symptomatic Distress Index—PSDI assesses re-
sponse style). Reliability analyses reveal that the nine dimensions yielded values close to or
higher than 0.70. The scale has high validity (concurrent and predictive), using as criteria
other clinical assessment instruments, screening scales, psychiatric diagnoses, structured
assessment protocols, or relapse indicators. This is published in TEA editions [22].
Addiction Severity Index, European version (EuropASI; [23]). This is a semi-structured
and standardized interview that assesses the severity of alcohol and drug dependence
by analyzing problems related to consumption. It provides information on the patient’s
situation at the time of assessment. It consists of 150 items grouped into six scales: (1) med-
ical situation (16 items); (2) work and social situation (26 items); (3) drug and alcohol
consumption (28 items); (4) legal situation (23 items); (5) family and social relationships
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(26 items), and (6) psychopathological state (22 items). In each area, objective questions are
asked that measure the number, extent, and duration of problem symptoms throughout
the patient’s life and in the last 30 days. Its application lasts between 40 and 50 min.
Information is obtained on the severity of the problem, which is quantified on a scale from
0 to 9. It is a hetero-rated scale, and prior training is necessary. After completing each
scale, the participant is asked about their degree of concern or discomfort. These subjective
items are rated by the patient on a 5-point scale: 0 (not at all), 1 (slightly), 2 (moderately),
3 (considerably), and 4 (extremely). This provides the interviewer with an assessment
of the truthfulness of the information reported by the patient, specifically regarding the
intention to provide distorted responses. The interviewer’s assessment is based on the
responses given to the objective items. It provides a rating estimated by the evaluator with
a score ranging between 0 and 9. Concerning the validity of the interviews that assess the
severity of the disorder, it should be noted that, from the clinical point of view, EuroPASI
provides information to describe the needs of patients at the beginning of treatment, assign
patients to appropriate therapeutic strategies, and evaluate the results of interventions.
Both ASI and EuropASI are widely used interviews whose reliability and validity have
been confirmed by recent research [24–26].
Impulsivity Scale (UPPS-P; [15]). This is composed of 59 items measuring five dimen-
sions of impulsivity: negative urgency (12 items), lack of perseverance (10 items), lack of
premeditation (11 items), sensation seeking (12 items), and positive urgency (14 items). The
items are scored on a Likert scale ranging from 1 (strongly agree) to 4 (strongly disagree).
The Spanish version of the scale has shown good psychometric properties [27].
Obsessive Beliefs Questionnaire (OBQ-44; [16]). This evaluates dysfunctional (ob-
sessive) beliefs. It consists of 44 Likert-scale items ranging from 1 (strongly disagree)
to 7 (strongly agree). It is composed of three dimensions, which are responsibility and
overestimation of threat (OBQ-RT) with 16 items, perfectionism and intolerance of un-
certainty (OBQ-PC) with 16 items, and importance and control of thoughts (OBQ- ICT)
with 12 items. The questionnaire presents adequate levels of reliability, an internal consis-
tency of 0.95 for the total score, 0.89 for the responsibility/estimation of threat dimension,
0.88 for the perfectionism/uncertainty dimension, and 0.85 for the importance/control
of thoughts dimension. With respect to the test-retest reliability, the coefficients are high
for both the total (0.80) and for the dimensions (responsibility/estimation of threat = 0.74;
perfectionism/uncertainty = 0.75; importance/control of thoughts = 0.79) [28].
2.3. Ethical Considerations
The Ethics Committee of the University of Granada approved the study (approval
number 396/CEIH/2018). Participation was voluntary and anonymous, and all partici-
pants were informed about the purpose, methods, and course of the study and their right
to refuse or discontinue participation. Written informed consent was obtained from each
participant before inclusion, and the research complied with the principles proposed by
the Declaration of Helsinki [29].
2.4. Statistical Methods
The variables (socio-demographic variables, such as marital status, educational level,
crimes committed (which could be up to two), and history of drug use and severity of use)
were compared using contingency tables and the likelihood-ratio test (Chis-Square—χ2)
was applied. Second, analysis of variance (ANOVA) was conducted using a between-
groups factorial design with group (adherent versus non-adherent) as the independent
variable, and the age of the participants as the dependent variable. Third, multivariate
analysis of variance (MANOVA) was performed with an intergroup factorial design using
group (adherent versus non-adherent) as the independent variable and the scores on the
six dimensions that comprise the Drug Use Severity Index (EuroPASI—medical situation;
work and social situation; drug and alcohol use; legal situation; family and social rela-
tionships, and psychopathological state) as the dependent variables. Fourth, in order to
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achieve the objectives of this study, two multivariate analysis of variance (MANCOVA)
were carried out with a one-factor between-groups design, using, in the first case, group
(adherent versus non-adherent) and the variables of the Impulsivity Scale (UPPS-P: Lack of
premeditation; negative urgency; lack of perseverance; sensation seeking; positive urgency)
as independent variables and the EuroPASI total score as dependent variables and as
covariate variables. Univariate ANCOVAs were then conducted for each of the dependent
variable levels (lack of premeditation; negative urgency; lack of perseverance; sensation
seeking; positive urgency) using group as the independent variable and the EuroPASI
total score as a covariate. In the second multivariate analysis of variance (MANCOVA),
with a one-factor between-groups design, the independent variable was group (adherent
versus non-adherent) and the variables of the Obsessive Beliefs Questionnaire (OBQ-44)
(responsibility/inhibition; perfectionism/uncertainty; importance/control) were depen-
dent variables, while the EuroPASI Total Score was used as a covariate. Subsequently,
univariate ANCOVAs were conducted for each of the dependent variable levels (responsi-
bility/inhibition; perfectionism/uncertainty, and importance/control) using group as an
independent variable and the EuroPASI Total Score as a covariate.
3. Results
3.1. Socio-Demographic, Delinquency, and Drug Use Variables of the Sample Studied
The study included 134 male participants from the Albolote Penitentiary Center of
Granada with a mean age of 37.48 years (SD = 8.31; 20–54 years). The participants were
divided into two groups according to their adherence to treatment. Group 1 was considered
treatment adherent and was composed of 56 men with a mean age of 38.7 years (SD = 7.6).
Group 2 was considered non-adherent and was composed of 78 men with a mean age
of 36.6 years (SD = 8.7). The groups were age matched (F1,132 = 2.211; Mce = 151.412;
p = 0.139). Table 1 shows the results obtained for the socio-demographic, delinquency, and
drug use variables of the sample.
3.2. Results of Impulsivity Between-Group Comparisons (Adherent versus Non-Adherent)
The results derived from Impulsivity Scale (UPPS-P; [15]) revealed a statistically
significant main effect of group (Wilks’ Lambda = 0.741, F5,127 = 8.858; p < 0.001). The results
of the ANCOVAs showed that there were statistically significant differences in negative
urgency (F2,131 = 16.437; measure of the effect size (Mez)— = 688.238; p < 0.001), sensation
Seeking (F2,131 = 9.593; Mez = 552.028; p < 0.001), and positive urgency (F2,131 = 10.627;
Mez = 905.213; p < 0.001), with the non-adherent group obtaining higher sores than the
adherent group in all cases. No statistically significant differences were found in the
variables of lack of premeditation and lack of perseverance. Means, standard deviations,
significance, and effect sizes are shown in Table 2.




Mean (SD) F η
2
Lack of Premeditation 21.46 (6.53) 20.92 (5.86) 0.499 (ns) 0.008
Negative Urgency 32.11 (7.79) 33.56 (6.70) 160.437 *** 0.201
Lack of Perseverance 19.61 (6.49) 19.64 (8.05) 10,097 (ns) 0.016
Sensation Seeking 33.54 (7.82) 35.03 (8.23) 90.593 *** 0.128
Positive Urgency 32.64 (10.22) 33.81 (9.66) 100.627 *** 0.140
Note: *** p < 0.001; ns = not significant. η2 = The proportion of the total variance in the dependent variables.
UPPS = Impulsivity Scale.
3.3. Results of Obsessive Belief Between-Group (Adherent versus Non-Adherent) Comparisons
The results derived from Obsessive Belief Questionnaire (OBQ-44; [16]) revealed
statistically significant group differences in responsibility/inhibition (F2,131 = 4.761,
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Mez = 1202.233; p < 0.05), perfectionism/uncertainty (F2,131 = 5.317, Mez = 1473.834;
p < 0.01), and importance/control of thoughts (F2,131 = 4.138, Mez = 763.739; p < 0.05), with
the non-adherent group obtaining higher scores than the adherent group. Means, standard
deviations, significance, and effect sizes are displayed in Table 3.
Table 3. Mean, standard deviation, and significance level of differences Obsessive Belief Question-
naire (OBQ-44) between the groups.
OBQ-44 Adherent Mean(SD)
Non-Adherent
Mean (SD) F η
2
Responsibility/Inhibition 68.32 (15.20) 72.74 (16.96) 40.761 * 0.068
Perfectionism/Uncertainty 70.30 (15.84) 74.74 (17.96) 50.317 ** 0.075
Importance/Control of thoughts 37.95 (12.32) 42.33 (14.74) 40.138 * 0.059
Note: ** p < 0.01; * p < 0.05; ns = not significant. η2 = The proportion of the total variance in the dependent
variables. Obsessive Belief Questionnaire = OBQ-44.
4. Discussion
Impulsivity and compulsivity underlie violent behaviors. Impulsive behavior appears
to be associated with reduced frontal lobe activity, whereas compulsive behavior appears
to be associated with increased activity in this region. Treatment adherence studies have
shown that impulsivity plays a negative role, whereas nothing is known about the role
of compulsivity in treatment adherence. This study therefore aimed to assess the role of
compulsivity and impulsivity in treatment adherence in the prison population.
The objective of treatment in penitentiary institutions is the re-education and reinte-
gration of inmates, i.e., to ensure that the inmate has the intention and the ability to live
law-abiding lives. Therefore, when looking at adherence to this type of intervention, the
role of self-control in particular, and of executive functions in general, are elements that
cannot be overlooked. The ability to plan, organize, guide, review, regulate, and evaluate
behavior is necessary for the inmate to adapt effectively to the prison environment and
achieve both short- and long-term goals. To do this, the inmate will need to re-organize
his/her belief system, motives, and values. Similarly, therapy in correctional institutions
should ensure adequate intervention for both increased frontal lobe activity (which char-
acterizes impulsive behavior) and decreased frontal lobe activity (which characterizes
compulsive behavior).
Our study aimed to evaluate the role of impulsivity and compulsivity in treatment
adherence in the prison population.
In this study, we found statistically significant differences in impulsivity in the dimen-
sions of negative urgency, sensation seeking, and positive urgency, with the non-adherent
group obtaining higher scores than the adherent group. Negative urgency is understood
as the tendency to engage in risky behaviors or act rashly under negative affectivity, re-
gardless of the negative consequences that could ensue. Positive urgency is understood as
the tendency to engage in risky actions or lose control when faced with intense positive
emotions. Moreover, sensation seeking is defined as the tendency to engage in and enjoy
activities with a high emotional component and to be open to new experiences that could
be dangerous. This study suggests that to increase treatment adherence, we should imple-
ment intervention programs aimed at managing intense emotional states (both positive
and negative) to regulate impulsive behavior. In addition, in such programs, we should
also encourage activities of daily living that increase the degree of personal well-being
so that inmates do not have to resort to risky behaviors that negatively affect health, the
legal system, and society. These results are consistent with previous studies [6,7] in which
smokers with high impulsivity scores were found to show non-adherence to treatment.
Likewise, our results are congruent with those obtained by another study [20] in which it
was found that most inmates in correctional facilities presented characteristics related to
impulsivity.
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We also found statistically significant differences in responsibility/inhibition, perfec-
tionism/uncertainty, and importance/control, with the non-adherent group again showing
higher scores compared to the adherent group. These results suggest that non-adherent
participants have higher scores on dysfunctional obsessive-compulsive beliefs compared
to adherent participants. Dysfunctional obsessive-compulsive beliefs include an inflated
sense of responsibility, overestimation of threat, perfectionism, intolerance of uncertainty,
the over importance of thoughts, and the need to control such thoughts. We can consider
our results to be entirely novel since, to date, no study has been conducted that analyzes
the role of compulsivity in treatment adherence in the prison population. These results
suggest that to increase adherence to treatment, we should design intervention strategies
that address conceptual rigidity, overestimation of threats, excessive responsibility, and
perfectionism. The first two (conceptual rigidity and overestimation of threat) are charac-
teristics that make it challenging to design an intervention adapted to the prison context,
since this is a rigid and very strict environment in terms of compliance with the rules.
However, the latter two elements (excessive responsibility and perfectionism) could be
more readily addressed within the penitentiary context and could even favor the acquisition
of penitentiary benefits (e.g., obtaining permission to leave, or gaining the social approval
of the professionals of the penitentiary center). However, we have found that these
characteristics (excessive responsibility and perfectionism) are related to non-adherence
to treatment, whereas it might be logical to think that these traits are related to adherence
to treatment. Both of these traits can be difficult to manage due to constant overexertion
and dissatisfaction with the fulfillment of tasks; hence, after starting treatment, they have
problems with adherence. When things do not go as they wish, behaviors incompatible
with adherence to treatment emerge [30].
In summary, the results of this research lead to clinical applications in four ways:
firstly, to design adequate frontal lobe dysfunction intervention; secondly, to encourage
activities necessary for independent living at the prison or in the community; thirdly, to
plan coping strategies that approach new challenges, tasks, and problems each day; and
finally, fourthly, to the performance of daily activities that achieve the proposed goals.
This study is the first investigation to analyze the role of impulsivity and compulsivity
concerning adherence to treatment in the inmate population. However, this work is not
without limitations. For example, we consider the measurement instrument used to assess
compulsivity to be a significant limitation, although this is currently the only available
instrument that has been adapted and validated for the Spanish population to assess
impulsivity. A second limitation is that the study sample was composed only of men. This
is because we considered the crime of gender violence, which is defined as aggression by
men against women, and because the male prison population is five times larger than that
of women so that the selection of a gender-balanced sample (based on the inclusion and
exclusion criteria) would not have been possible.
5. Conclusions
Treatment adherence is related to the management of intense emotional states (both
positive and negative); the performance of daily activities that generate well-being or
reduce threats; the ability to adapt to novel, rigid, changing, or unexpected situations; and
the achievement of the proposed goals.
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